Adenosine receptor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Adenosine receptor" in English language version.

refsWebsite

Global rank English rank

36nih.gov

4^th place

23doi.org

2^nd place

2web.archive.org

1^st place

1aspetjournals.org

6,663^rd place

5,792^nd place

1zenodo.org

621^st place

380^th place

1handle.net

102^nd place

76^th place

1yale.edu

565^th place

460^th place

1mhmedical.com

6,846^th place

4,957^th place

1harvard.edu

18^th place

17^th place

1books.google.com

3^rd place

aspetjournals.org (Global: 6,663^rd place; English: 5,792^nd place)

pharmrev.aspetjournals.org

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors". Pharmacol. Rev. 53 (4): 527–52. doi:10.1016/S0031-6997(24)01511-4. PMC 9389454. PMID 11734617. Archived from the original on 2018-12-03. Retrieved 2007-10-31.

books.google.com (Global: 3^rd place; English: 3^rd place)

Khayat MT, Hanif A, Geldenhuys WJ, Nayeem MA (2019). "Adenosine Receptors and Drug Discovery in the Cardiovascular System". In Choudhary MI (ed.). Frontiers in Cardiovascular Drug Discovery: Volume 4. Amazon Digital Services LLC - Kdp. pp. 16–64. ISBN 978-1-68108-400-8. Retrieved 23 September 2024.

doi.org (Global: 2^nd place; English: 2^nd place)

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M (1997). "Towards a revised nomenclature for P1 and P2 receptors". Trends Pharmacol. Sci. 18 (3): 79–82. doi:10.1016/S0165-6147(96)01038-3. PMC 4460977. PMID 9133776.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors". Pharmacol. Rev. 53 (4): 527–52. doi:10.1016/S0031-6997(24)01511-4. PMC 9389454. PMID 11734617. Archived from the original on 2018-12-03. Retrieved 2007-10-31.
Gao ZG, Jacobson KA (September 2007). "Emerging adenosine receptor agonists". Expert Opinion on Emerging Drugs. 12 (3): 479–92. doi:10.1517/14728214.12.3.479. PMC 11790296. PMID 17874974.
Haskó G, Pacher P (March 2008). "A2A receptors in inflammation and injury: lessons learned from transgenic animals". Journal of Leukocyte Biology. 83 (3): 447–55. doi:10.1189/jlb.0607359. PMC 2268631. PMID 18160539.
Kalda A, Yu L, Oztas E, Chen JF (October 2006). "Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease". Journal of the Neurological Sciences. 248 (1–2): 9–15. doi:10.1016/j.jns.2006.05.003. PMID 16806272.
Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF (September 2007). "Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function". Physiology & Behavior. 92 (1–2): 210–7. doi:10.1016/j.physbeh.2007.05.034. hdl:11380/584545. PMID 17572452.
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S (December 2007). "Adenosine A2A receptors and basal ganglia physiology". Progress in Neurobiology. 83 (5): 277–92. doi:10.1016/j.pneurobio.2007.05.001. PMC 2148496. PMID 17646043.
Cunha RA, Ferré S, Vaugeois JM, Chen JF (2008). "Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders". Current Pharmaceutical Design. 14 (15): 1512–24. doi:10.2174/138161208784480090. PMC 2423946. PMID 18537674.
Peart JN, Headrick JP (May 2007). "Adenosinergic cardioprotection: multiple receptors, multiple pathways". Pharmacology & Therapeutics. 114 (2): 208–21. doi:10.1016/j.pharmthera.2007.02.004. PMID 17408751.
Cohen MV, Downey JM (May 2008). "Adenosine: trigger and mediator of cardioprotection". Basic Research in Cardiology. 103 (3): 203–15. doi:10.1007/s00395-007-0687-7. PMID 17999026.
Ferré S (May 2008). "An update on the mechanisms of the psychostimulant effects of caffeine". Journal of Neurochemistry. 105 (4): 1067–79. doi:10.1111/j.1471-4159.2007.05196.x. PMID 18088379.
Osadchii OE (June 2007). "Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease". Cardiovascular Drugs and Therapy. 21 (3): 171–94. doi:10.1007/s10557-007-6014-6. PMID 17373584.
Baraldi PG, Tabrizi MA, Gessi S, Borea PA (January 2008). "Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility". Chemical Reviews. 108 (1): 238–63. doi:10.1021/cr0682195. PMID 18181659.
Cristalli G, Lambertucci C, Marucci G, Volpini R, Dal Ben D (2008). "A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists". Current Pharmaceutical Design. 14 (15): 1525–52. doi:10.2174/138161208784480081. PMID 18537675.
He W, Wilder T, Cronstein BN (2013). "Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist". Br J Pharmacol. 170 (6): 1167–1176. doi:10.1111/bph.12342. PMC 3838692. PMID 23962057.
Jacobson KA, Gao ZG (2006). "Adenosine receptors as therapeutic targets". Nature Reviews. Drug Discovery. 5 (3): 247–64. doi:10.1038/nrd1983. PMC 3463109. PMID 16518376.
Mediero A, Frenkel SR, Wilder T, HeW MA, Cronstein BN (2012). "Adenosine A2A receptor activation prevents wearparticle-induced osteolysis". Sci Transl Med. 4 (135): 135–165. doi:10.1126/scitranslmed.3003393. PMID 22623741.
Mediero A, Kara FM, Wilder T, Cronstein BN (2012). "Adenosine A 2A receptor ligation inhibits osteoclast formation". Am J Pathol. 180 (2): 775–786. doi:10.1016/j.ajpath.2011.10.017. PMC 3349861. PMID 22138579.
Theparambil, Shefeeq M.; Kopach, Olga; Braga, Alice; Nizari, Shereen; Hosford, Patrick S.; Sagi-Kiss, Virag; Hadjihambi, Anna; Konstantinou, Christos; Esteras, Noemi; Gutierrez Del Arroyo, Ana; Ackland, Gareth L.; Teschemacher, Anja G.; Dale, Nicholas; Eckle, Tobias; Andrikopoulos, Petros; Rusakov, Dmitri A.; Kasparov, Sergey; Gourine, Alexander V. (August 2024). "Adenosine signalling to astrocytes coordinates brain metabolism and function". Nature. 632 (8023): 139–146. Bibcode:2024Natur.632..139T. doi:10.1038/s41586-024-07611-w. PMC 11291286. PMID 38961289.
Costa MA, Barbosa A, Neto E, Sá-e-Sousa A, Freitas R, Neves JM, Magalhães-Cardoso T, Ferreirinha F, Correia-de-Sá P (2011). "On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells". J Cell Physiol. 226 (5): 1353–1366. doi:10.1002/jcp.22458. PMID 20945394.
Carroll SH, Ravid K (2013). "Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: a focus on adenosine receptors". Expert Reviews in Molecular Medicine. 15 e1. doi:10.1017/erm.2013.2. PMID 23406574.
Müller CE, Jacobson KA (May 2011). "Recent developments in adenosine receptor ligands and their potential as novel drugs". Biochim Biophys Acta. 1808 (5): 1290–1308. doi:10.1016/j.bbamem.2010.12.017. PMC 3437328. PMID 21185259.
Müller CE, Jacobson KA (2011). "Xanthines as Adenosine Receptor Antagonists". Methylxanthines. Handbook of Experimental Pharmacology. Vol. 200. pp. 151–199. doi:10.1007/978-3-642-13443-2_6. ISBN 978-3-642-13442-5. PMC 3882893. PMID 20859796.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF (September 2007). "Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function". Physiology & Behavior. 92 (1–2): 210–7. doi:10.1016/j.physbeh.2007.05.034. hdl:11380/584545. PMID 17572452.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Theparambil, Shefeeq M.; Kopach, Olga; Braga, Alice; Nizari, Shereen; Hosford, Patrick S.; Sagi-Kiss, Virag; Hadjihambi, Anna; Konstantinou, Christos; Esteras, Noemi; Gutierrez Del Arroyo, Ana; Ackland, Gareth L.; Teschemacher, Anja G.; Dale, Nicholas; Eckle, Tobias; Andrikopoulos, Petros; Rusakov, Dmitri A.; Kasparov, Sergey; Gourine, Alexander V. (August 2024). "Adenosine signalling to astrocytes coordinates brain metabolism and function". Nature. 632 (8023): 139–146. Bibcode:2024Natur.632..139T. doi:10.1038/s41586-024-07611-w. PMC 11291286. PMID 38961289.

mhmedical.com (Global: 6,846^th place; English: 4,957^th place)

accessmedicine.mhmedical.com

Ong, MH; Lim, S; Venkataraman, A (2016). "23: Defibrillation and Cardioversion". Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8e. McGraw-Hill Education. ISBN 978-0071794763. Retrieved 30 March 2024.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M (1997). "Towards a revised nomenclature for P1 and P2 receptors". Trends Pharmacol. Sci. 18 (3): 79–82. doi:10.1016/S0165-6147(96)01038-3. PMC 4460977. PMID 9133776.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors". Pharmacol. Rev. 53 (4): 527–52. doi:10.1016/S0031-6997(24)01511-4. PMC 9389454. PMID 11734617. Archived from the original on 2018-12-03. Retrieved 2007-10-31.
Gao ZG, Jacobson KA (September 2007). "Emerging adenosine receptor agonists". Expert Opinion on Emerging Drugs. 12 (3): 479–92. doi:10.1517/14728214.12.3.479. PMC 11790296. PMID 17874974.
Haskó G, Pacher P (March 2008). "A2A receptors in inflammation and injury: lessons learned from transgenic animals". Journal of Leukocyte Biology. 83 (3): 447–55. doi:10.1189/jlb.0607359. PMC 2268631. PMID 18160539.
Kalda A, Yu L, Oztas E, Chen JF (October 2006). "Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease". Journal of the Neurological Sciences. 248 (1–2): 9–15. doi:10.1016/j.jns.2006.05.003. PMID 16806272.
Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF (September 2007). "Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function". Physiology & Behavior. 92 (1–2): 210–7. doi:10.1016/j.physbeh.2007.05.034. hdl:11380/584545. PMID 17572452.
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S (December 2007). "Adenosine A2A receptors and basal ganglia physiology". Progress in Neurobiology. 83 (5): 277–92. doi:10.1016/j.pneurobio.2007.05.001. PMC 2148496. PMID 17646043.
Cunha RA, Ferré S, Vaugeois JM, Chen JF (2008). "Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders". Current Pharmaceutical Design. 14 (15): 1512–24. doi:10.2174/138161208784480090. PMC 2423946. PMID 18537674.
Peart JN, Headrick JP (May 2007). "Adenosinergic cardioprotection: multiple receptors, multiple pathways". Pharmacology & Therapeutics. 114 (2): 208–21. doi:10.1016/j.pharmthera.2007.02.004. PMID 17408751.
Cohen MV, Downey JM (May 2008). "Adenosine: trigger and mediator of cardioprotection". Basic Research in Cardiology. 103 (3): 203–15. doi:10.1007/s00395-007-0687-7. PMID 17999026.
Ferré S (May 2008). "An update on the mechanisms of the psychostimulant effects of caffeine". Journal of Neurochemistry. 105 (4): 1067–79. doi:10.1111/j.1471-4159.2007.05196.x. PMID 18088379.
Osadchii OE (June 2007). "Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease". Cardiovascular Drugs and Therapy. 21 (3): 171–94. doi:10.1007/s10557-007-6014-6. PMID 17373584.
Baraldi PG, Tabrizi MA, Gessi S, Borea PA (January 2008). "Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility". Chemical Reviews. 108 (1): 238–63. doi:10.1021/cr0682195. PMID 18181659.
Cristalli G, Lambertucci C, Marucci G, Volpini R, Dal Ben D (2008). "A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists". Current Pharmaceutical Design. 14 (15): 1525–52. doi:10.2174/138161208784480081. PMID 18537675.
He W, Wilder T, Cronstein BN (2013). "Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist". Br J Pharmacol. 170 (6): 1167–1176. doi:10.1111/bph.12342. PMC 3838692. PMID 23962057.
Jacobson KA, Gao ZG (2006). "Adenosine receptors as therapeutic targets". Nature Reviews. Drug Discovery. 5 (3): 247–64. doi:10.1038/nrd1983. PMC 3463109. PMID 16518376.
Mediero A, Frenkel SR, Wilder T, HeW MA, Cronstein BN (2012). "Adenosine A2A receptor activation prevents wearparticle-induced osteolysis". Sci Transl Med. 4 (135): 135–165. doi:10.1126/scitranslmed.3003393. PMID 22623741.
Mediero A, Kara FM, Wilder T, Cronstein BN (2012). "Adenosine A 2A receptor ligation inhibits osteoclast formation". Am J Pathol. 180 (2): 775–786. doi:10.1016/j.ajpath.2011.10.017. PMC 3349861. PMID 22138579.
Theparambil, Shefeeq M.; Kopach, Olga; Braga, Alice; Nizari, Shereen; Hosford, Patrick S.; Sagi-Kiss, Virag; Hadjihambi, Anna; Konstantinou, Christos; Esteras, Noemi; Gutierrez Del Arroyo, Ana; Ackland, Gareth L.; Teschemacher, Anja G.; Dale, Nicholas; Eckle, Tobias; Andrikopoulos, Petros; Rusakov, Dmitri A.; Kasparov, Sergey; Gourine, Alexander V. (August 2024). "Adenosine signalling to astrocytes coordinates brain metabolism and function". Nature. 632 (8023): 139–146. Bibcode:2024Natur.632..139T. doi:10.1038/s41586-024-07611-w. PMC 11291286. PMID 38961289.
Costa MA, Barbosa A, Neto E, Sá-e-Sousa A, Freitas R, Neves JM, Magalhães-Cardoso T, Ferreirinha F, Correia-de-Sá P (2011). "On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells". J Cell Physiol. 226 (5): 1353–1366. doi:10.1002/jcp.22458. PMID 20945394.
Carroll SH, Ravid K (2013). "Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: a focus on adenosine receptors". Expert Reviews in Molecular Medicine. 15 e1. doi:10.1017/erm.2013.2. PMID 23406574.
Müller CE, Jacobson KA (May 2011). "Recent developments in adenosine receptor ligands and their potential as novel drugs". Biochim Biophys Acta. 1808 (5): 1290–1308. doi:10.1016/j.bbamem.2010.12.017. PMC 3437328. PMID 21185259.
Müller CE, Jacobson KA (2011). "Xanthines as Adenosine Receptor Antagonists". Methylxanthines. Handbook of Experimental Pharmacology. Vol. 200. pp. 151–199. doi:10.1007/978-3-642-13443-2_6. ISBN 978-3-642-13442-5. PMC 3882893. PMID 20859796.

ncbi.nlm.nih.gov

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M (1997). "Towards a revised nomenclature for P1 and P2 receptors". Trends Pharmacol. Sci. 18 (3): 79–82. doi:10.1016/S0165-6147(96)01038-3. PMC 4460977. PMID 9133776.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors". Pharmacol. Rev. 53 (4): 527–52. doi:10.1016/S0031-6997(24)01511-4. PMC 9389454. PMID 11734617. Archived from the original on 2018-12-03. Retrieved 2007-10-31.
Gao ZG, Jacobson KA (September 2007). "Emerging adenosine receptor agonists". Expert Opinion on Emerging Drugs. 12 (3): 479–92. doi:10.1517/14728214.12.3.479. PMC 11790296. PMID 17874974.
Haskó G, Pacher P (March 2008). "A2A receptors in inflammation and injury: lessons learned from transgenic animals". Journal of Leukocyte Biology. 83 (3): 447–55. doi:10.1189/jlb.0607359. PMC 2268631. PMID 18160539.
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S (December 2007). "Adenosine A2A receptors and basal ganglia physiology". Progress in Neurobiology. 83 (5): 277–92. doi:10.1016/j.pneurobio.2007.05.001. PMC 2148496. PMID 17646043.
Cunha RA, Ferré S, Vaugeois JM, Chen JF (2008). "Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders". Current Pharmaceutical Design. 14 (15): 1512–24. doi:10.2174/138161208784480090. PMC 2423946. PMID 18537674.
He W, Wilder T, Cronstein BN (2013). "Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist". Br J Pharmacol. 170 (6): 1167–1176. doi:10.1111/bph.12342. PMC 3838692. PMID 23962057.
"Entrez Gene: ADORA2A adenosine A2A receptor".
Jacobson KA, Gao ZG (2006). "Adenosine receptors as therapeutic targets". Nature Reviews. Drug Discovery. 5 (3): 247–64. doi:10.1038/nrd1983. PMC 3463109. PMID 16518376.
Mediero A, Kara FM, Wilder T, Cronstein BN (2012). "Adenosine A 2A receptor ligation inhibits osteoclast formation". Am J Pathol. 180 (2): 775–786. doi:10.1016/j.ajpath.2011.10.017. PMC 3349861. PMID 22138579.
Theparambil, Shefeeq M.; Kopach, Olga; Braga, Alice; Nizari, Shereen; Hosford, Patrick S.; Sagi-Kiss, Virag; Hadjihambi, Anna; Konstantinou, Christos; Esteras, Noemi; Gutierrez Del Arroyo, Ana; Ackland, Gareth L.; Teschemacher, Anja G.; Dale, Nicholas; Eckle, Tobias; Andrikopoulos, Petros; Rusakov, Dmitri A.; Kasparov, Sergey; Gourine, Alexander V. (August 2024). "Adenosine signalling to astrocytes coordinates brain metabolism and function". Nature. 632 (8023): 139–146. Bibcode:2024Natur.632..139T. doi:10.1038/s41586-024-07611-w. PMC 11291286. PMID 38961289.
Müller CE, Jacobson KA (May 2011). "Recent developments in adenosine receptor ligands and their potential as novel drugs". Biochim Biophys Acta. 1808 (5): 1290–1308. doi:10.1016/j.bbamem.2010.12.017. PMC 3437328. PMID 21185259.
Müller CE, Jacobson KA (2011). "Xanthines as Adenosine Receptor Antagonists". Methylxanthines. Handbook of Experimental Pharmacology. Vol. 200. pp. 151–199. doi:10.1007/978-3-642-13443-2_6. ISBN 978-3-642-13442-5. PMC 3882893. PMID 20859796.

web.archive.org (Global: 1^st place; English: 1^st place)

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). "International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors". Pharmacol. Rev. 53 (4): 527–52. doi:10.1016/S0031-6997(24)01511-4. PMC 9389454. PMID 11734617. Archived from the original on 2018-12-03. Retrieved 2007-10-31.
Unless else specified in boxes, then ref is:senselab Archived 2009-02-28 at the Wayback Machine

yale.edu (Global: 565^th place; English: 460^th place)

senselab.med.yale.edu

Unless else specified in boxes, then ref is:senselab Archived 2009-02-28 at the Wayback Machine

zenodo.org (Global: 621^st place; English: 380^th place)

Gao ZG, Jacobson KA (September 2007). "Emerging adenosine receptor agonists". Expert Opinion on Emerging Drugs. 12 (3): 479–92. doi:10.1517/14728214.12.3.479. PMC 11790296. PMID 17874974.

Adenosine receptor (English Wikipedia)

aspetjournals.org (Global: 6,663rd place; English: 5,792nd place)

pharmrev.aspetjournals.org

books.google.com (Global: 3rd place; English: 3rd place)

doi.org (Global: 2nd place; English: 2nd place)

handle.net (Global: 102nd place; English: 76th place)